Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer
Open Access
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (2) , 183-186
- https://doi.org/10.1023/a:1008352123009
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinomaCancer, 2000
- Biliary Tract CancersNew England Journal of Medicine, 1999
- The role of chemotherapy and radiation in the management of biliary cancer: a review of the literatureEuropean Journal Of Cancer, 1998
- Efficacy of gemcitabine in the treatment of patients with gallbladder carcinomaCancer, 1998
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1997
- Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabineInvestigational New Drugs, 1996
- Approximate Confidence Intervals for Probabilities of Survival and Quantiles in Life-Table AnalysisPublished by JSTOR ,1982
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958